Jasper Therapeutics, Inc. (JSPR) has a consensus analyst rating of Buy, based on 12 analysts covering the stock. Of those, 8 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for JSPR is $41.67, representing a +4,369.1% upside from the current price of $0.9324. Price targets range from a low of $3.00 to a high of $65.00.
